Q32 Bio Inc. (QTTB) › Cash & EquivalentsQ32 Bio Inc. (QTTB) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2016: $11.39M2017: $51.58M2018: $38.22M2019: $53.77M2020: $217.43M2021: $108.38M2022: $33.99M2023: $25.62M2024: $77.97M2025: $48.30M$48.30M2016Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$48.30M-38.1%2024$77.97M+204.3%2023$25.62M-24.6%2022$33.99M-68.6%2021$108.38M-50.2%2020$217.43M+304.3%2019$53.77M+40.7%2018$38.22M-25.9%2017$51.58M+352.7%2016$11.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share